GlassScriptPhysician profile
Mihir K Maniar
NPI 1659387264
$9,733.33
in general payments reported to CMS, 2019-2025
41 companies · $1,577 in 2025
The $1,577 reported for 2025 was more than what 91% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,557 · 2020: $1,170 · 2021: $1,612 · 2022: $894 · 2023: $1,295 · 2024: $1,629 · 2025: $1,577.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,501.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,500.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $3,266.79 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $924.90 | 2020-2025 | |
| Pfizer INC. | $799.72 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $739.21 | 2019-2025 | Airsupra, Breztri, Fasenra |
| Glaxosmithkline, LLC. | $523.15 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Lilly USA, LLC | $517.67 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $357.93 | 2019-2025 | Otezla, Repatha, Repatha |
| Exact Sciences Corporation | $345.59 | 2023-2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $344.05 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $208.78 | 2019-2022 | |
| Amarin Pharma, INC. | $193.30 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $185.05 | 2019-2023 | Austedo Xr |
| Takeda Pharmaceuticals U.S.A., INC. | $182.53 | 2019-2021 | |
| Abbott Laboratories | $172.95 | 2020-2025 | Freestyle Libre 3 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $148.93 | 2019-2025 | Xifaxan |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mihir Maniar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.